as of 12-05-2025 3:43pm EST
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.
| Founded: | 1985 | Country: | United States |
| Employees: | N/A | City: | DUBLIN |
| Market Cap: | 25.9B | IPO Year: | 1992 |
| Target Price: | $268.25 | AVG Volume (30 days): | 653.3K |
| Analyst Decision: | Buy | Number of Analysts: | 9 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 6.97 | EPS Growth: | 59.39 |
| 52 Week Low/High: | $200.98 - $268.60 | Next Earning Date: | 11-05-2025 |
| Revenue: | $5,702,415,000 | Revenue Growth: | 7.08% |
| Revenue Growth (this year): | 9.24% | Revenue Growth (next year): | 6.30% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Sr. VP and GM, Life Sciences
Avg Cost/Share
$262.00
Shares
5,008
Total Value
$1,312,096.00
Owned After
10,710
V.P. & Corporate Treasurer
Avg Cost/Share
$257.74
Shares
5,036
Total Value
$1,297,039.68
Owned After
7,195
Sr. VP, Gen Counsel, and Sec.
Avg Cost/Share
$265.14
Shares
15,000
Total Value
$3,977,100.00
Owned After
33,669
SEC Form 4
President and CEO
Avg Cost/Share
$241.82
Shares
159
Total Value
$38,449.38
Owned After
51,096
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Madsen Julia | STE | Sr. VP and GM, Life Sciences | Nov 21, 2025 | Sell | $262.00 | 5,008 | $1,312,096.00 | 10,710 | |
| Tamaro Renato | STE | V.P. & Corporate Treasurer | Nov 18, 2025 | Sell | $257.74 | 5,036 | $1,297,039.68 | 7,195 | |
| Zangerle John Adam | STE | Sr. VP, Gen Counsel, and Sec. | Nov 11, 2025 | Sell | $265.14 | 15,000 | $3,977,100.00 | 33,669 | |
| Carestio Daniel A | STE | President and CEO | Oct 6, 2025 | Sell | $241.82 | 159 | $38,449.38 | 51,096 |
STE Breaking Stock News: Dive into STE Ticker-Specific Updates for Smart Investing
See how STE stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "STE STERIS plc (Ireland) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.